gene expression analysis
Geneticprofiles of HPV(+) and (-) HNSCCs
NCT Number: NCT00899340
RATIONALE: Studying the proteins expressed in samples of tumor tissue from patients with cancer may help doctors identify and learn more about biomarkers related to cancer. It may also help doctors plan better treatment for patients with cancer of the oropharynx.
PURPOSE: This laboratory study is looking at protein expression in tumor tissue samples from patients with cancer of the oropharynx.
Looking for future studies?
Notify MeAll sexes
Observational
OBJECTIVES:
OUTLINE: Archived tumor tissue samples are analyzed for expression of standard immunohistological markers (e.g., p16, p53, and Ki-67) as well as expression of genes identified in a previous gene expression study. Protein expression data are tested for clinical and demographic correlates and compared with gene expression data.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
PRIOR CONCURRENT THERAPY:
profiles of HPV(+) and (-) HNSCCs
microarray analysis
Other names: SAM - significance Analysis of microarrays
protein expression analysis
immunohistochemistry staining method
laboratory biomarker analysis
Time frame: after 7 months of tissue collection
Time frame: after 7months of tissue collection
Vanderbilt-Ingram Cancer Center
Other
Protein Expression Profiles in Oropharyngeal Squamous Cell Carcinoma
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00076310
Carcinoma, Carcinoma, Squamous Cell
Houston, Texas, United States
View Trial DetailsNCT01302834
Carcinoma, Carcinoma, Squamous Cell
Anchorage, Alaska, United States
View Trial DetailsNCT02308072
Carcinoma, Carcinoma, Squamous Cell
London, United Kingdom
View Trial DetailsNCT03336606
Carcinoma, Carcinoma, Squamous Cell
Portland, Oregon, United States
View Trial Details